Clinical Trial Update: Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled budesonide/formoterol for bronchiolitis obliterans after allogeneic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bronchiolitis Obliterans, Allogeneic Stem Cell Transplantation | Phase 2 | Status: COMPLETED